Insight Molecular Diagnostics (IMDX) Net Cash Flow (QoQ) (2015 - 2026)
Insight Molecular Diagnostics (IMDX) Net Cash Flow (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Insight Molecular Diagnostics | 172.94 Mn | 144.01 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 326.03% |
| Dec 31, 2025 | -28.28% |
| Sep 30, 2025 | 16.11% |
| Jun 30, 2025 | -130.17% |
| Mar 31, 2025 | 324.79% |
| Dec 31, 2024 | 189.85% |
| Sep 30, 2024 | -259.65% |
| Jun 30, 2024 | 195.43% |
| Mar 31, 2024 | 11.42% |
| Dec 31, 2023 | -21.37% |
| Sep 30, 2023 | -164.42% |
| Jun 30, 2023 | 157.37% |
| Mar 31, 2023 | 8.06% |
| Dec 31, 2022 | 17.47% |
| Sep 30, 2022 | -152.34% |
| Jun 30, 2022 | 260.76% |
| Mar 31, 2022 | -96.42% |
| Dec 31, 2021 | -144.62% |
| Sep 30, 2021 | 74.51% |
| Jun 30, 2021 | -123.96% |